Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
Koepenicker Str. 325
12555 Berlin, Germany
Germany
Phone: +49-30-65762396
Fax: +49-30-65762397
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
BioGenes GmbH, founded in 1992, is a worldwide acting full-service provider for customized immunoassay and antibody development with strong commitment to quality and service. BioGenes has a twenty-year proven track record in the development, validation and production of highly sensitive and robust ELISAs for a variety of applications. Our scientists are experts in multi-product (platform) and specific host cell protein (HCP) assays. We work to the highest quality standards required by the FDA and EMA. The company has developed a unique approach that increases the specificity and sensitivity of generic HCP assays. The enhanced generic 360-HCP assay provides four kits, each using a different set of anti-HCP antibodies so you can choose the one that works best for your process. Our scientists have developed countless monoclonal and polyclonal antibodies against all kinds of antigens: peptides, soluble proteins, membrane protein, antibodies (anti-idiotypic), phosphorylated antigens, haptens and small toxic molecules. We offer a comprehensive range of analytical services which meet all your requirements for custom antibody and assay development. Summary services/products Custom ELISA development (multi-product and process-specific HCP ELISAs, Immunogenicity and PK ELISAs, Diagnostic ELISAs) Generic HCP ELISA Kits (for CHO cells and E.coli) Custom polyclonal antibodies Custom monoclonal antibodies Anti-idiotypic antibodies Analytical services (2D Western Blot, DIGE, Immunoaffinity Chromatography)
Selected Categories:
Last update of this entry: August 09, 2022
|